Novel transketolase inhibitor oroxylin A suppresses the non‐oxidative pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient‐derived organoids-Reference-Cited by-同舟云学术

Novel transketolase inhibitor oroxylin A suppresses the non‐oxidative pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient‐derived organoids

Published:2022-10-31 Issue:11 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Jia Dan¹²³⁴,Liu Chunliang¹,Zhu Zhenyu²,Cao Yan²,Wen Wen¹³,Hong Zhanying²,Liu Yue²,Liu Erdong¹³,Chen Long²,Chen Chun²⁵,Gu Yanqiu²⁵,Jiao Binghua⁴^ORCID,Chai Yifeng²,Wang Hong‐yang¹³,Fu Jing¹³,Chen Xiaofei¹²³^ORCID

Affiliation:

1. International Cooperation Laboratory on Signal Transduction Eastern Hepatobiliary Surgery Hospital Second Military Medical University/Naval Medical University Shanghai China

2. School of Pharmacy Second Military Medical University/Naval Medical University Shanghai China

3. National Center for Liver Cancer Second Military Medical University/Naval Medical University Shanghai China

4. Department of Biochemistry and Molecular Biology College of Basic Medical Second Military Medical University/Naval Medical University Shanghai China

5. Department of Pharmacy Shanghai Ninth People's Hospital School of Medicine of Shanghai Jiao Tong University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1095

Reference43 articles.

1. Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate

2. Metabolic reprogramming and cancer progression